Life Technologies completes previously announced acquisition of BioTrove

Download PDF Copy

Dec 16 2009

Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today announced that it has completed the previously announced acquisition of BioTrove, Inc. for an undisclosed amount.

BioTrove’s primary technology is the OpenArray^® platform, a high throughput gene expression and genotyping analysis system based on a flexible array format that enables researchers to perform more than 3,000 PCR genotyping or qPCR gene expression assays at a time.

As previously announced, Life Technologies does not expect this transaction to have a material effect on its financials in fiscal year 2009.

http://www.lifetechnologies.com/

Posted in:

Comments (0)

Download PDF Copy

Suggested Reading

Clonogenic hepatocytes identified as engines of liver development

Bacteria use density switch to balance virulence and growth

Genetic variant disrupts brain’s cleanup crew increasing Alzheimer’s risk

Gene expression maps explain why diseases often occur together

Epigenomic erosion linked to cognitive decline in Alzheimer’s patients

Gene editing therapy exa-cel improves quality of life in sickle cell disease and beta thalassemia

Shared gene signatures reveal metabolic dysfunction in liver cirrhosis and acute-on-chronic liver failure

Genetic mutation in some East Asians linked to aldehyde storm and increased liver disease risk

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.